跳至主要内容
临床试验/DRKS00010656
DRKS00010656招募中不适用

IDEAL-RegisterIluvien®- implant in chronic diabetic macular edema - IDEAL-Register

Alimera Sciences Ophthalmologie GmbH0 个研究点目标入组 350 人开始时间: 2016年6月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
350

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • •The patient (male / female) is at least 18 years old
  • •- The patient is treated with Iluvien® according to the summary of product characteristics
  • •- Treatment with Iluvien® is decided independently of the study
  • •- a written consent for study participation exists

排除标准

  • •contraindications according to the SmPC of Iluvien®, for example when the patient is suffering from a pre-existing glaucoma or an active or suspected infection of the eye or periocular region or known hypersensitivity to any component of Iluvien.

研究者

相似试验